Market Cap (In KRW)
1444.04 Billion
Revenue (In KRW)
1375.32 Billion
Net Income (In KRW)
111.5 Billion
Avg. Volume
73.83 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 100100.0-164400.0
- PE
- -
- EPS
- -
- Beta Value
- 0.774
- ISIN
- KR7069620003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Chang-Jae Lee
- Employee Count
- -
- Website
- https://www.daewoong.com
- Ipo Date
- 2005-09-29
- Details
- Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
More Stocks
-
TCRRFTerrace Energy Corp.
TCRRF
-
KHRNF
-
6054Livesense Inc.
6054
-
8511
-
600032
-
014580Taekyung Bk Co., Ltd
014580
-
XELPMOCXelpmoc Design and Tech Limited
XELPMOC
-
300694